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Abstract
Background: To study the value and safety of aqueous humor polymerase chain reaction (PCR) analysis for Herpes
simplex, varicella zoster, cytomegalovirus, Epstein-Barr virus and Toxoplasma gondii in patients with uveitis.
Methods: Records of 45 consecutive patients with anterior and posterior uveitis who underwent AC paracentesis
with PCR were reviewed. The main outcome measure was frequency of PCR positivity. Secondary outcomes were
alteration of treatment, safety of paracentesis, and correlation of keratitic precipitates with PCR positivity,
Results: The overall PCR positivity was 48.9 % (22/45). Therapy was changed because of the PCR results in 14/45
patients (37.7 %). One patient experienced a paracentesis related complication (1/45, 2.2 %) without long-term sequelae.
Conclusion: Aqueous PCR altered the diagnosis and treatment in over a third of our patients and was relatively safe.
Aqueous PCR should be considered for uveitis of atypical clinical appearance, recurrent severe uveitis of uncertain
etiology, and therapy refractory cases.
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Background
Rapid analysis of aqueous humor by polymerase chain
reaction (PCR) in uveitis can be very helpful in leading
to a specific diagnosis of infectious etiology and efficient
treatment [1–7]. However, aqueous humor PCR analysis
is not routine and remains controversial because of a
low proportion of therapeutic change based on the PCR
results in some studies, invasiveness of paracentesis
bearing potential complications, and false negatives and
positives [5–7]. On these grounds recent reports even
question its utility and discourage its practice in anterior
uveitis [5, 8]. Recent reports discourage aqueous PCR
for the diagnosis of infectious uveitis or favour PCR of
vitreous over aqueous [5, 9, 10].
Although in most cases the working diagnosis of
uveitis is based on history and clinical signs, supported
by routine blood tests and radiological examinations,
diagnostic error can cause increased ocular morbidity
and establishing a definitive etiology often can be chal-
lenging. Quick identification of infectious etiology is par-
ticularly important in management of posterior uveitis
because fundus lesions caused by viruses, bacteria, fungi
or parasites cannot always be clearly distinguished, espe-
cially in the presence of opaque vitreous. Also, the sig-
nificant proportion of uveitis characterized as idiopathic
might be reduced if PCR testing were performed [11].
In this study we report the results of aqueous PCR
analysis for infectious agents and the rate of treatment
change based on the PCR results in patients with anter-
ior, posterior, intermediate uveitis, and panuveitis, as
well as the complication rate of paracentesis. We also
analyze the association of keratic precipitates with PCR
positivity and suggest guidelines for performing a safe
anterior chamber paracentesis at the slitlamp.
Methods
This study was carried out following institutional guide-
lines and ethical standards of the 1964 Declaration of
Helsinki and its later amendments and was approved by
the local ethical committee of the Geneva University
Hospitals and School of Medicine (Commission cantonale
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d'éthique de la recherche CCER) (No. 15-188). A retro-
spective review of consecutive patients with anterior, pos-
terior, intermediate uveitis and panuveitis who underwent
aqueous PCR analysis was performed by cross-referencing
the PCR test list of the Institute for Immunology and
Microbiology with the clinical database of the Department
of Ophthalmology from January 1, 2011 to March 1, 2015
and yielded 45 uveitis patients (45 eyes).
The 45 patients’ records were reviewed for initial work-
ing diagnosis, disease course, signs and degree of ocular
inflammation prior to paracentesis, clinical rationale for
paracentesis, intraocular pressure, PCR results, and para-
centesis complications. The grading and classification of
uveitis followed the Standardization of Uveitis Nomencla-
ture (SUN) recommendations [12]. In all cases, diagnostic
AC paracentesis was performed at the slit lamp following
topical anesthesia, disinfection with povidone-iodine, and
placement of a sterile lid speculum. A 27- or 30-gauge
needle on a 3 ml syringe was used to extract about 0.2 ml
of aqueous humor. Semi-quantitative real-time PCR
(rt-PCR) was performed within 24 h of sample collection
for Herpes simplex (HSV1/2), varicella zoster virus
(VZV), cytomegalovirus (CMV), Epstein-Barr virus (EBV)
and Toxoplasma gondii DNA. Nucleic acid from aqueous
humor was extracted using the EasyMag Nuclisens® (bio-
Mérieux Inc., Durham, NC, USA) (100 μl eluted in 25 μl
respectively) and used for rt-PCR with an in-house vali-
dated method on a StepOne Plus ABI® machine (Thermo
Fisher Scientific Inc, Waltham, MA USA). A signal de-
tected during the first 40 cycles revealed the presence of
foreign DNA. The primers and probes sequences used for
the detection of HSV 1/2, VZV, CMV, EBV and Toxo-
plasma gondii DNA are given in Table 1.
The primary outcome measure was the frequency of
PCR positivity. Secondary outcomes were change in treat-
ment based on the PCR results, safety profile of diagnostic
AC paracentesis, and correlation between keratic precipi-
tates (KP) and positive PCR results.
Descriptive statistics were applied to continuous
data while categorical data were assessed using IBM
SPSS statistical software version 20 (SPSS, Inc, Chicago,
Illinois, USA).
Results
Demographics of the 45 patients are presented in Table 2.
Five of the 45 patients underwent repeated paracentesis
(average 2.6) because of a negative PCR result in patients
strongly suspected of having infectious uveitis, so there
were 53 samples in total. Mean age was 43.6 ± 18 years
with a female to male ratio of 1:1.6. Indications for
paracentesis were: 6.7 % (3/45) recurrent anterior uveitis,
13.3 % (6/45) hypertensive anterior uveitis (Posner
Schlossman syndrome) (PSS), 13.3 % (6/45) anterior uveitis
of suspected viral/microbial etiology based on clinical
features including granulomatous KP and iris atrophy,
4.5 % 2/45) anterior uveitis with suspicion of Fuchs
heterochromic uveitis syndrome (FUS), 44.4 % (20/45)
suspected viral/microbial posterior uveitis, 15.6 % (7/
45) panuveitis, and 2.2 % (1/45) intermediate uveitis
of uncertain etiology. Table 3 outlines the overall re-
sults and subgroup analysis for PCR positivity. In 21
of the 45 patients (six anterior uveitis, 11 posterior
uveitis, one intermediate uveitis, three panuveitis)
sampling occurred without previous anti-inflammatory,
antiviral treatment. Seven patients (three anterior uve-
itis and four posterior uveitis) were already under
anti-inflammatory therapy at the time of sampling
which did not change. Five patients (three anterior
uveitis and two posterior uveitis) were already on
anti-infectious before sampling, which changed follow-
ing the result of PCR analysis. Three posterior uveitis,
four panuveitis and five anterior uveitis had no anti-
infectious therapy prior to PCR testing but then re-
ceived it after PCR analysis.
Overall PCR positivity
In total, 22/53 samples were positive for presence of
foreign DNA (41.5 %). Two samples from one patient
drawn within 48 h were positive for the same pathogen
and counted only once in the analysis. 7/45 patients
(15.6 %) were immunosuppressed at the time of paracen-
tesis, 5 with Adamantiadis-Behçet vasculitis and already
on corticosteroids, 1 suspected to have Birdshot choriore-
tinopathy, and 1 with bilateral posterior uveitis and
occlusive vasculitis of unknown etiology.
Table 1 PCR primers and probes sequences
HSV Forward 5’- CCGTCAGCACCTTCATCGA -3’
Reverse 5’-CGCTGGACCTCCGTGTAGTC -3’
Probe 5’-CCACGAGATCAAGGACAGCGGCC-3’
VZV Forward 5’- CGG CAT GGC CCG TCT AT -3’
Reverse 5’-TCG CGT GCT GCG GC -3’
Probe 5’-ATT CAG CAA TGG AAA CAC ACG ACG CC-3’
Toxo Forward 5'- AGA GAC ACC GGA ATG CGA TCT - 3'
Reverse 5'- CCC TCT TCT CCA CTC TTC AAT TCT – 3'
Probe 5' -ACG CTT TCC TCG TGG TGA TGG CG -3'
EBV Forward 5'- CGG AAG CCC TCT GGA CTT C -3’
Reverse 5'- CCC TGT TTA TCC GAT GGA ATG -3’
Probe 5'- TGT ACA CGC ACG AGA AAT GCG CC -3’
CMV Forward 5'- GATCCGCTGACGCGTTTG-3’
Reverse 5'- GCCGCCAGTCGTAACGAT-3’
Probe 5'- TCATCGATCGGCGGATCACCAC -3’
The presence of foreign DNA was assessed by semi-quantitative rt-PCR. Table
1 demonstrates the PCR primers and probes sequences for HSV, VZV, CMV,
EBV and Toxoplasma gondii that were used
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Table 2 Patient demographics
Age Working Diagnosis PCR CMV HSV VZV EBV Toxoplasma Treatment altered
1 22 Uveitis posterior, Adamantiadis-Behçet neg
2 47 Toxoplasma retinitis pos* + yes
3 28 Uveitis anterior, Posner Schlossman pos*,** + (+)
4 30 Uveitis posterior, ARN pos + yes
5 54 Recurrent granulomatous anterior uveitis neg yes
6 32 Recurrent nongranulomatous anterior uveitis neg
7 78 Recurrent granulomatous anterior uveitis with iris atrophy pos + yes
8 14 Toxoplasma retinitis pos + yes
9 31 Toxoplasma retinitis pos + yes
10 52 Posterior uveitis, Birdshot neg
11 23 Uveitis posterior, Adamantiadis-Behçet neg
12 47 Anterior uveitis, suspicion on FUS pos +
13 61 Posterior uveitis, ARN pos* +
14 26 Posterior uveitis, Adamantiadis-Behçet neg
15 30 Posterior uveitis, Adamantiadis-Behçet neg
16 22 Acute anterior uveitis neg
17 47 Acute anterior uveitis neg
18 78 Intermediate uveitis neg
19 41 Anterior uveitis neg
20 43 Panuveitis granulomatous pos + yes
21 20 Panuveitis neg
22 58 Panuveitis, Adamantiadis-Behçet pos + yes
23 29 Anterior uveitis, nongranulomatous, hypertensive neg yes
24 73 Posterior uveitis, ARN pos* + yes
25 27 Posterior uveitis pos** (+) +
26 19 Panuveitis pos + yes
27 23 Panuveitis pos** (+) + yes
28 54 Anterior uveitis, Posner Schlossman pos + yes
29 36 Anterior uveitis, Posner Schlossman neg* yes
30 45 Anterior uveitis, Posner Schlossman pos + yes
31 65 Anterior uveitis, suspicion FUS pos + yes
32 28 Posterior uveitis, vasculitis neg
33 39 Posterior uveitis, VKH neg
34 26 Posterior uveitis neg
35 68 Posterior uveitis neg
36 68 Posterior uveitis, Toxoplasma retinitis pos +
37 58 Panuveitis, occlusive vasculitis neg
38 22 Posterior uveitis, vasculitis neg
39 39 Panuveitis neg
40 81 Anterior uveitis pos +
41 19 Posterior uveitis neg
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Patients with anterior uveitis
Of the 17 patients with anterior uveitis, 9 were PCR
positive: 4 positive for HSV (2 suspicious for FUS, 1
PSS, and 1 acute granulomatous anterior uveitis), 3 posi-
tive for CMV (clinically with PSS), and 2 positive for
VZV (1 PSS with double positivity for EBV and 1 recur-
rent granulomatous anterior uveitis with iris atrophy).
The remaining 8 patients were negative: 5 with acute an-
terior uveitis and 3 with recurrent anterior uveitis.
Patients with posterior uveitis
Of the 20 patients with posterior uveitis, 9 were PCR posi-
tive: 5 clinically diagnosed with toxoplasmosis also posi-
tive for Toxoplasma gondii and 1 positive also for HSV, 2
positive for VZV with clinical acute retinal necrosis
(ARN), and 1 positive for EBV also with ARN. The
remaining 11 patients were PCR negative and were finally
diagnosed as: 4 Adamantiadis-Behçet's retinitis, 1 Birdshot
chorioretinopathy, 1 Vogt-Koyanagi-Harada (VKH) syn-
drome, 2 vasculitis of undetermined etiology, and 3 un-
determined posterior uveitis.
Patients with panuveitis or intermediate uveitis
Of the 7 patients with panuveitis, 3 were PCR positive for
Toxoplasma gondii alone, one for Toxoplasma gondii and
EBV, 3 PCR negative. The one patient with intermediate
uveitis was PCR negative.
Treatment change based on PCR
Treatment was changed based on PCR results in 17/45
patients (37.7 %): 9/17 anterior uveitis (53 %), 4/20 pos-
terior uveitis (20 %), and 4/7 panuveitis patients (57 %),
all of whom responded favorably. One patient with
recurrent VZV associated anterior uveitis was placed on
valaciclovir; two patients with acute retinal necrosis (one
VZV and one EBV associated) were placed on ganciclovir;
7 patients positive for Toxoplasma gondii were placed on
antibiotics; 3 patients with PSS (two CMV positive and
one HSV positive) received systemic valaciclovir replaced
later on by topical 2 % ganciclovir solution and systemic
valaciclovir respectively and one presumed FUS patient fi-
nally tested positive for HSV1 and was placed on systemic
acyclovir. In 3 anterior uveitis patients after negative PCR
with repeated testing, acyclovir was discontinued and re-
placed with topical corticosteroids.
Association of KP with PCR positivity
The association of KP with infectious uveitis is con-
firmed; 16/21 KP positive eyes had a positive PCR
(76.2 %) whereas only 6/24 KP negative eyes had a posi-
tive PCR (25 %) (Table 4). Sensitivity and specificity were
72.7 % and 78.3 % respectively (p = 0.002, Chi square =
9.8, power = 0.9). In the subgroup analysis on HSV, VZV,
CMV, EBV and Toxoplasma gondii, the percentage of
KP presence with PCR positivity was 80 %, 75 %, 100 %,
66.7 % and 70 % respectively (Table 4).
Safety profile
Only one patient developed what appeared to be a
paracentesis-related complication, increased anterior cham-
ber inflammation (2.2 %) and was hospitalized for 24 h
without long-term sequelae.
Discussion
Diagnostic uncertainty and dilemmas are common in
the management of uveitis. In this study, aqueous PCR
analysis was of considerable diagnostic value with 48.9 %
Table 3 Overall and subgroup PCR positivity
Patient PCR Positivity 22 out of 45 (48.9 %) (95 % CI 46 %-51 %)
Sample Positivity 22 out of 53 (41.5 %)
Diagnosis # PCR positivity
Anterior uveitis 17/45 (37.8 %) 9/17 (52.9 %)
Posterior uveitis 20/45 (44.4 %) 9/20 (45 %)
Panuveitis 7/45 (15.6 %) 4/7 (57.1 %)
Intermediate uveitis 1/45 (2.2 %) 0 %
Overall and subgroup PCR positivity according to uveitis diagnoses
Table 4 Correlation between keratitic precipitates (KP) and
PCR results
PCR + KP + KP - % PCR positive with KP
HSV 4 1 80
CMV 3 1 100
VZV 3 0 75
EBV 2 1 66.7
Toxoplasma 7 1 70
Overall and subgroup PCR positivity in correlation with the presence or
absence of KPs and the infectious agents detected. 16/21 KP positive eyes had
a positive PCR whereas only 6/24 KP negative eyes had a positive PCR
Table 2 Patient demographics (Continued)
42 69 Recurrent anterior uveitis, Posner Schlossman pos + yes
43 38 Acute anterior uveitis neg
44 49 Recurrent anterior uveitis, Posner Schlossman pos +
45 43 Posterior uveitis pos +
Demonstrates the patient cohort demographics which included 28 men and 17 women with a mean age of 43 years. Aqueous humor of 22 patients was PCR
positive for either CMV, HSV, VZV, EBV or Toxoplasma gondii. 5 patients were tested multiple times, indicated by a *. 3 patients were PCR positive for two
infectious agents, indicated by a **. Potentially false positive results are noted in parenthesis
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of patients positive for infectious DNA leading to a
change in diagnosis and treatment in over a third of the
patients (37.7 %), all of whom responded favorably to
the new treatment. It is likely that with a larger test bat-
tery for foreign DNA, the yield of detection of specific
infectious pathogens would be even greater. PCR from
ocular fluids has a very high reliability with a very low
false-positive rate [13–16]. False negative results are
more difficult to verify as there is no gold standard for
the accuracy of PCR and viral or Toxoplasma gondii cul-
tures are rarely performed [17].
Aqueous PCR analysis in uveitis has been previously re-
ported [5–7, 15, 18, 19]. Harper et al. reported a 20 %
change in the management of patients with posterior uve-
itis following PCR results [6] and Rothova et al. reported
foreign DNA in 29 % of posterior uveitis patients with a
change in management in 24 %. Anwar et al. reported
positivity for foreign DNA in only 13 % of 53 anterior uve-
itis patients leading to a change in management in 24 %,
only 3 % of the total study group, and expressed doubts
about its usefulness [5, 7].
At present, with limited PCR testing, infectious causes
represent around 20-30 % of all uveitis with Herpes vi-
ruses the most common cause of anterior uveitis in
Western countries [20–23]. Our subgroup analysis sup-
ports this finding. A viral etiology was particularly fre-
quent in hypertensive anterior uveitis with 85.7 % (6/7)
of patients positive for CMV, VZV or HSV. The presence
of an infectious agent was also confirmed in two cases of
suspected FUS found to be positive for the Herpes virus
genome and who were treated accordingly. In our poster-
ior uveitis patients, we observed a high prevalence of
Toxoplasma gondii (10/45, 22.2 %) and lower rates of
CMV, HSV and VZV positivity compared to Asian and
US studies which reported CMV or CMV and HSV as
leading infectious causes followed by Toxoplasma gondii
[6, 19]. Previous systematic surveys on uveitis from
Western Europe confirm Toxoplasmosis as the most
common cause of infectious posterior uveitis which
could be related to local customs of consumption of very
rare meat and raw chopped steak [23–25]. Aqueous PCR
testing for Toxoplasma gondii seems to be reliable and
not influenced by the interval between symptom onset
and paracentesis or host immune status but rather by
the total size of the retinal lesions [18, 26]. Furthermore
aqueous PCR testing can be particularly useful for exclud-
ing an infectious aetiology in immunocompromised or
older patients as the clinical presentation can be atypical
and misleading [15, 26–29], in severe anterior uveitis
cases with no fundal view, in severe presumed HLA-B27
uveitis [30] and in cases of presumed infectious poster-
ior uveitis with atypical and sight-threatening inflam-
mation where a rapid and sensitive diagnosis from
prompt sampling for PCR analysis is crucial.
Three patients, one PSS, one posterior uveitis, and one
panuveitis, were double positive, for VZV and EBV, EBV
and Toxoplasma gondii, and HSV and Toxoplasma gon-
dii, respectively, with weak signals for both EBV and
Toxoplasma gondii. In these double positive cases, ther-
apy was influenced by clinical criteria with close follow-
up. Double PCR positivity, which can lead to diagnostic
challenges, has been previously reported in immunosup-
pressed or otherwise immunocompromised patients and
may be caused by dormant latent viruses or parasites ac-
tivated secondary to acute infectious uveitis [6, 31–33].
In the particular case of EBV, a major limitation is pos-
sible cross reactivity with B lymphocytes containing EBV
genome in a latent phase, which can lead to false posi-
tive results [13]. This phenomenon of dual positivity has
been observed in previous studies and in particular in
immunocompromised patients; in those cases PCR testing
of ocular fluids helps substantially, testing for multiple
pathogens before taking the final decision for treatment
based on clinical appearance as the phenotype of the in-
traocular inflammation can be misleading in such cases.
The complication rate of anterior chamber paracen-
tesis in uveitis is low as corroborated in our study [34].
Paracentesis performed at the slit lamp has a low com-
plication rate if: 1) collaborative adult patients with a
deep anterior chamber are selected; 2) the eye is prop-
erly prepared; 3) a speculum is used; and 4) careful
follow-up is possible. Otherwise, paracentesis supine
using an operating microscope and appropriate sedation
or anesthesia may be indicated. In our experience, it is
essential that the hand holding the syringe be braced se-
curely on the patient’s face and not on the frame of the
slit lamp and that the patient’s head rests firmly on the
head and chin rests to reduce head movement. Informed
consent is required including as potential complications
endophthalmitis, corneal abscess, hyphema, conversion to
vitreous sampling, and trauma to the cornea, iris, lens,
and posterior segment.
Our study has several limitations. First, it was per-
formed in a tertiary care center including uveitis patients
in whom there was a strong suspicion for infectious
etiology creating a possible referral and selection bias.
Furthermore, different geographic locations have differ-
ent frequency/prevalence of uveitis pathogens and PCR
detection thresholds may vary accordingly between
studies [5, 19, 35]. While our study demonstrates a 48.9 %
positivity for foreign DNA, the use of antivirals prior to
paracentesis may have reduced the virus load below
detectable levels in some patients. Finally, although FUS
has been strongly associated with rubella virus, it was not
tested in our study [36]. One further pathogen that was
not tested with PCR but which merits consideration in
relevant clinical settings is Treponema pallidum [37].
Although Treponema pallidum infections were considered
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almost eradicated in developed countries, epidemio-
logic studies confirm steady increase of primary syphilis
infections with a considerable percentage of secondary,
ocular manifestations requiring prompt diagnosis and
treatment [38, 39].
Conclusion
Aqueous PCR analysis is easy to perform, safe, and valu-
able, establishing a correct etiologic diagnosis and change
in treatment in about a third of selected uveitis cases. We
consider aqueous PCR most useful for uveitis with atypical
clinical appearance, recurrent severe uveitis of uncertain
etiology, and treatment-resistant cases. In suspected infec-
tious uveitis where retinal examination may be limited by
vitreous opacification prompt intraocular fluid sampling is
necessary and important in reaching a preliminary diag-
nosis and administering therapy. Regardless, empiric treat-
ment should be initiated based on the clinical picture in
severe, sight-threatening uveitis cases with no delay; this
can be further adjusted depending on PCR results; negative
results can be useful in excluding infectious etiology. In the
future, a larger battery of PCR tests for infectious agents
will probably become routine for diagnosing infectious
uveitis with even better accuracy.
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